Orthostatic Hypotension Among Veterans
NCT02123303 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2019-03-01
Summary
Orthostatic hypotension (OH) is defined as a fall in blood pressure when standing. Several different underlying diseases, conditions, or combinations of medicines may contribute to OH; therefore the cause of the condition varies among individuals. Some studies have shown that OH is associated with an increase in the rate of death, but it is not clear what role OH plays in increased morbidity. By studying what the prevalence of OH is in a generalized veteran population we expect increase clinical awareness of the degree of the problem so that patient care might be improved.
Conditions
- Hypotension, Orthostatic Hypotension
Sponsors & Collaborators
-
James J. Peters Veterans Affairs Medical Center
lead FED
Principal Investigators
-
Jill M Wecht, EdD · James J. Peters VAMC
Eligibility
- Min Age
- 18 Years
- Max Age
- 89 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-11-30
- Primary Completion
- 2015-07-31
- Completion
- 2015-07-31
Countries
- United States
Study Locations
More Related Trials
-
A Novel Device for the Treatment of Postural Hypotension - a Signal of Effectiveness Study.
NCT06039410 ·Status: RECRUITING ·Phase: NA
-
A Study in Subjects With Neurogenic Orthostatic Hypotension
NCT07089043 ·Status: RECRUITING ·Phase: PHASE2
-
Dose Response to the Norepinephrine Precursor Droxidopa in Hypotensive Individuals With Spinal Cord Injury
NCT03602014 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess the Benefit of Midodrine in the Treatment of Patients With Neurogenic Orthostatic Hypotension
NCT00555880 ·Status: COMPLETED ·Phase: PHASE4
-
Phase II Study of Midodrine for Neurogenic Orthostatic Hypotension
NCT00004268 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Tolerance of Flucortac in Patients With Orthostatic Neurogenic Hypotension
NCT04128137 ·Status: UNKNOWN ·Phase: PHASE4
-
Cardiovagal Baroreflex Deficits Impair Neurovascular Coupling and Cognition in POTS
NCT03261570 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Using Mirabegron to Increase BP in Patients With POTS
NCT06133075 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
NCT02897063 ·Status: RECRUITING ·Phase: PHASE1
-
Assessment of Metoprolol in the Prevention of Vasovagal Syncope in Aging Subjects
NCT02123056 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Effect of Exercise in OI
NCT00770484 ·Status: COMPLETED ·Phase: NA
-
Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients
NCT04620382 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Autonomic Determinants of POTS - Pilot 2
NCT04140721 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
NCT02429557 ·Status: COMPLETED ·Phase: PHASE1
-
Autonomic Determinants of POTS - Pilot1
NCT04050410 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Hemodynamic Response of Neuropathic And Non-Neuropathic POTS Patients To Adrenoreceptor Agonist And Antagonist
NCT03070730 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Use of Beta Blockers in Elderly Trauma Patients
NCT00302692 ·Status: UNKNOWN ·Phase: PHASE2
-
Water and the Gastropressor Response - Tachyphylaxis
NCT00580996 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Influence of Beta Blocker Therapy on the Hemodynamic Response to Inotrope Infusion in Patients With Acute Decompensated Heart Failure
NCT01971944 ·Status: COMPLETED
-
Clinical Relevance of Nicardipine Induced Hypoxemia in the Intensive Care Unit
NCT05155202 ·Status: UNKNOWN
-
Tilt-Table Study of the Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension
NCT01518946 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Autonomic Disorders: A Training Protocol
NCT02154009 ·Status: TERMINATED
-
Effect of Medical Treatment and Prognosis of Postural Orthostatic Tachycardia Syndrome (POTS)
NCT02171988 ·Status: COMPLETED ·Phase: PHASE4
-
Clonidine and Left Ventricular Dysfunction
NCT00213902 ·Status: WITHDRAWN
-
Safety Study of Pyridostigmine in Heart Failure
NCT01415921 ·Status: COMPLETED ·Phase: PHASE2